GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (OSTO:XBRANE) » Definitions » Cyclically Adjusted Book per Share

Xbrane Biopharma AB (OSTO:XBRANE) Cyclically Adjusted Book per Share : kr1.89 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Xbrane Biopharma AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Xbrane Biopharma AB's adjusted book value per share for the three months ended in Mar. 2024 was kr0.258. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.89 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-06), Xbrane Biopharma AB's current stock price is kr0.323. Xbrane Biopharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr1.89. Xbrane Biopharma AB's Cyclically Adjusted PB Ratio of today is 0.17.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Xbrane Biopharma AB was 0.20. The lowest was 0.11. And the median was 0.13.


Xbrane Biopharma AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Xbrane Biopharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Cyclically Adjusted Book per Share Chart

Xbrane Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xbrane Biopharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1.89

Competitive Comparison of Xbrane Biopharma AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Xbrane Biopharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xbrane Biopharma AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xbrane Biopharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Xbrane Biopharma AB's Cyclically Adjusted PB Ratio falls into.



Xbrane Biopharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xbrane Biopharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.258/132.2054*132.2054
=0.258

Current CPI (Mar. 2024) = 132.2054.

Xbrane Biopharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.419 100.541 0.551
201409 0.000 100.161 0.000
201412 0.303 100.225 0.400
201503 0.000 99.950 0.000
201506 0.000 99.995 0.000
201509 2.698 100.228 3.559
201512 -0.288 100.276 -0.380
201603 3.084 100.751 4.047
201606 2.940 101.019 3.848
201609 2.743 101.138 3.586
201612 2.574 102.022 3.336
201703 2.187 102.022 2.834
201706 1.910 102.752 2.457
201709 1.905 103.279 2.439
201712 1.595 103.793 2.032
201803 1.509 103.962 1.919
201806 0.944 104.875 1.190
201809 1.945 105.679 2.433
201812 1.411 105.912 1.761
201903 1.775 105.886 2.216
201906 2.569 106.742 3.182
201909 1.778 107.214 2.192
201912 1.172 107.766 1.438
202003 1.026 106.563 1.273
202006 1.125 107.498 1.384
202009 0.794 107.635 0.975
202012 1.316 108.296 1.607
202103 1.064 108.360 1.298
202106 0.764 108.928 0.927
202109 2.094 110.338 2.509
202112 1.955 112.486 2.298
202203 1.794 114.825 2.066
202206 1.649 118.384 1.842
202209 1.473 122.296 1.592
202212 1.751 126.365 1.832
202303 1.514 127.042 1.576
202306 1.552 129.407 1.586
202309 1.263 130.224 1.282
202312 0.652 131.912 0.653
202403 0.258 132.205 0.258

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Xbrane Biopharma AB  (OSTO:XBRANE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Xbrane Biopharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.323/1.89
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Xbrane Biopharma AB was 0.20. The lowest was 0.11. And the median was 0.13.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Xbrane Biopharma AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Xbrane Biopharma AB (OSTO:XBRANE) Business Description

Industry
Traded in Other Exchanges
Address
Retzius vag 8, Solna, SWE, 171 65
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company has a patented protein production platform with up to 12 times greater productivity than standard systems for the production of proteins in E.coli host cells. Xbrane's leading product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. The company's geographical segments include the Middle East, Asia, Europe, and the United States.

Xbrane Biopharma AB (OSTO:XBRANE) Headlines

No Headlines